Phase 2 study of JNJ-75220795
Latest Information Update: 20 Feb 2023
At a glance
- Drugs ARO PNPLA3 (Primary)
- Indications Fatty liver; Non-alcoholic steatohepatitis
- Focus Therapeutic Use
Most Recent Events
- 20 Feb 2023 New trial record
Latest Information Update: 20 Feb 2023